Multiplexed screening of natural humoral immunity identifies antibodies at fine specificity for complex and dynamic viral targets

References

• Glassy MC, Handley HH, Hagiwara H, Royston I. UC 729-6, a human lymphoblastoid B-cell line useful for generating antibody-secreting human-human hybridomas. Proc Natl Acad Sci U S A 1983; 80:6327 - 31; http://dx.doi.org/10.1073/pnas.80.20.6327; PMID: 6604917
   PubMed Web of Science ®Google Scholar
• Ter Meulen J. Monoclonal antibodies in infectious diseases: clinical pipeline in 2011. Infect Dis Clin North Am 2011; 25:789 - 802; http://dx.doi.org/10.1016/j.idc.2011.07.006; PMID: 22054756
   PubMed Web of Science ®Google Scholar
• Han T, Marasco WA. Structural basis of influenza virus neutralization. Ann N Y Acad Sci 2011; 1217:178 - 90; http://dx.doi.org/10.1111/j.1749-6632.2010.05829.x; PMID: 21251008
   PubMed Web of Science ®Google Scholar
• Pedersen J, Carlsen TH, Prentoe J, Ramirez S, Jensen TB, Forns X, Alter H, Foung SK, Law M, Gottwein J, et al. Neutralization resistance of hepatitis C virus can be overcome by recombinant human monoclonal antibodies. Hepatology 2013; 58:1587 - 97; http://dx.doi.org/10.1002/hep.26524; PMID: 23729237
   PubMed Web of Science ®Google Scholar
• Hammond PW. Accessing the human repertoire for broadly neutralizing HIV antibodies. MAbs 2010; 2:157 - 64; http://dx.doi.org/10.4161/mabs.2.2.11301; PMID: 20168075
   PubMed Web of Science ®Google Scholar
• Collarini EJ, Lee FE, Foord O, Park M, Sperinde G, Wu H, Harriman WD, Carroll SF, Ellsworth SL, Anderson LJ, et al. Potent high-affinity antibodies for treatment and prophylaxis of respiratory syncytial virus derived from B cells of infected patients. J Immunol 2009; 183:6338 - 45; http://dx.doi.org/10.4049/jimmunol.0901373; PMID: 19841167
   PubMed Web of Science ®Google Scholar
• Macagno A, Bernasconi NL, Vanzetta F, Dander E, Sarasini A, Revello MG, Gerna G, Sallusto F, Lanzavecchia A. Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex. J Virol 2010; 84:1005 - 13; http://dx.doi.org/10.1128/JVI.01809-09; PMID: 19889756
   PubMed Web of Science ®Google Scholar
• Thomson CA, Bryson S, McLean GR, Creagh AL, Pai EF, Schrader JW. Germline V-genes sculpt the binding site of a family of antibodies neutralizing human cytomegalovirus. EMBO J 2008; 27:2592 - 602; http://dx.doi.org/10.1038/emboj.2008.179; PMID: 18772881
   PubMed Web of Science ®Google Scholar
• Melchjorsen J. Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines. Viruses 2013; 5:470 - 527; http://dx.doi.org/10.3390/v5020470; PMID: 23435233
   PubMed Web of Science ®Google Scholar
• Wang S. Advances in the production of human monoclonal antibodies. Antibody Technology Journal 2011; http://dx.doi.org/10.2147/ANTI.S20195
   Google Scholar
• Beerli RR, Rader C. Mining human antibody repertoires. MAbs 2010; 2:365 - 78; PMID: 20505349
   PubMed Web of Science ®Google Scholar
• Harriman WD, Collarini EJ, Sperinde GV, Strandh M, Fatholahi MM, Dutta A, Lee Y, Mettler SE, Keyt BA, Ellsworth SL, et al. Antibody discovery via multiplexed single cell characterization. J Immunol Methods 2009; 341:135 - 45; http://dx.doi.org/10.1016/j.jim.2008.11.009; PMID: 19087879
   PubMed Web of Science ®Google Scholar
• Mancini N, Solforosi L, Clementi N, De Marco D, Clementi M, Burioni R. A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza. Antiviral Res 2011; 92:15 - 26; http://dx.doi.org/10.1016/j.antiviral.2011.07.013; PMID: 21798290
   PubMed Web of Science ®Google Scholar
• Ohlin M, Sundqvist VA, Mach M, Wahren B, Borrebaeck CA. Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies. J Virol 1993; 67:703 - 10; PMID: 7678304
   PubMed Web of Science ®Google Scholar
• Maidji E, McDonagh S, Genbacev O, Tabata T, Pereira L. Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis. Am J Pathol 2006; 168:1210 - 26; http://dx.doi.org/10.2353/ajpath.2006.050482; PMID: 16565496
   PubMed Web of Science ®Google Scholar
• Throsby M, van den Brink E, Jongeneelen M, Poon LL, Alard P, Cornelissen L, Bakker A, Cox F, van Deventer E, Guan Y, et al. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One 2008; 3:e3942; http://dx.doi.org/10.1371/journal.pone.0003942; PMID: 19079604
   PubMed Web of Science ®Google Scholar
• Sui J, Hwang WC, Perez S, Wei G, Aird D, Chen LM, Santelli E, Stec B, Cadwell G, Ali M, et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 2009; 16:265 - 73; http://dx.doi.org/10.1038/nsmb.1566; PMID: 19234466
   PubMed Web of Science ®Google Scholar
• Ekiert DC, Friesen RH, Bhabha G, Kwaks T, Jongeneelen M, Yu W, Ophorst C, Cox F, Korse HJ, Brandenburg B, et al. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 2011; 333:843 - 50; http://dx.doi.org/10.1126/science.1204839; PMID: 21737702
   PubMed Web of Science ®Google Scholar
• Corti D, Voss J, Gamblin SJ, Codoni G, Macagno A, Jarrossay D, Vachieri SG, Pinna D, Minola A, Vanzetta F, et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 2011; 333:850 - 6; http://dx.doi.org/10.1126/science.1205669; PMID: 21798894
   PubMed Web of Science ®Google Scholar
• Lantto J, Fletcher JM, Ohlin M. Binding characteristics determine the neutralizing potential of antibody fragments specific for antigenic domain 2 on glycoprotein B of human cytomegalovirus. Virology 2003; 305:201 - 9; http://dx.doi.org/10.1006/viro.2002.1752; PMID: 12504553
   PubMed Web of Science ®Google Scholar
• Xu MY, Xu XH, Chen GZ, Deng XL, Li J, Yu XJ, Chen MZ. Production of a human single-chain variable fragment antibody against esophageal carcinoma. World J Gastroenterol 2004; 10:2619 - 23; PMID: 15309706
   PubMed Web of Science ®Google Scholar
• Zhang ZC, Hu XJ, Yang Q. Generation of high affinity human single-chain antibody against PreS1 of hepatitis B virus from immune phage-display antibody library. Hepatobiliary Pancreat Dis Int 2004; 3:77 - 81; PMID: 14969843
   PubMedGoogle Scholar
• Cottey R, Rowe CA, Bender BS. Influenza Virus. Current Protocols in Immunology. 2001. Unit 19.11.
   Google Scholar
• Andreoni M, Faircloth M, Vugler L, Britt WJ. A rapid microneutralization assay for the measurement of neutralizing antibody reactive with human cytomegalovirus. J Virol Methods 1989; 23:157 - 67; http://dx.doi.org/10.1016/0166-0934(89)90129-8; PMID: 2542350
   PubMed Web of Science ®Google Scholar
• Timmerman P, Puijk WC, Meloen RH. Functional reconstruction and synthetic mimicry of a conformational epitope using CLIPS technology. J Mol Recognit 2007; 20:283 - 99; http://dx.doi.org/10.1002/jmr.846; PMID: 18074397
   PubMed Web of Science ®Google Scholar